Radius Health Announces First Quarter 2019 Operating Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Radius Health (RDUS) Misses Q1 EPS by 2c, Revenues Miss; Raises FY19 TYMLOS Sales Mid-Point Outlook
May 8, 2019 8:00 AM EDTRadius Health (NASDAQ: RDUS) reported Q1 EPS of ($0.94), $0.02 worse than the analyst estimate of ($0.92). Revenue for the quarter came in at $29.84 million versus the consensus estimate of $35.35 million.
I am very pleased to see continued strong market share gains by TYMLOS, which we... More
